(NYSE: BLCO) Bausch & Lomb's forecast annual revenue growth rate of 5.24% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.69%.
Bausch & Lomb's revenue in 2026 is $5,324,000,000.On average, 14 Wall Street analysts forecast BLCO's revenue for 2026 to be $1,991,910,576,942, with the lowest BLCO revenue forecast at $1,905,833,752,656, and the highest BLCO revenue forecast at $2,059,057,643,190. On average, 14 Wall Street analysts forecast BLCO's revenue for 2027 to be $2,104,774,794,678, with the lowest BLCO revenue forecast at $1,995,839,394,648, and the highest BLCO revenue forecast at $2,177,279,339,616.
In 2028, BLCO is forecast to generate $2,215,853,186,184 in revenue, with the lowest revenue forecast at $2,081,916,218,934 and the highest revenue forecast at $2,301,572,845,224.